DRIO
DarioHealth Corp.
Key Financials
Operating Income
$-36655000
↑ 36.5%
Gross Profit
$12.7M
↓ 4.5%
Revenue
$7.4M
↑ 43.0%
EPS (Diluted)
$10.12
↑ 1559.0%
Total Assets
$110.1M
↓ 7.4%
Net Income
$-41714000
↑ 2.4%
Cash & Equivalents
$21.8M
↓ 21.5%
Operating Cash Flow
$-25941000.00
↑ 32.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 4 | 9/28/2026 | View on SEC |
| 3 | 9/28/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DRIO |
| Company Name | DarioHealth Corp. |
| CIK | 1533998 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 972-4-770-6377 |